Maguinda, Flora Mae C.
HRN: 09-78-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2023
CEFUROXIME 1.5GM (VIAL)
08/18/2023
08/19/2023
IV
1.5gm 4 Doses
Q8
S/P Pelvic Lap
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes